Cargando…
Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8(+) T Cell Responses
Due to its safety and efficacy, aluminum hydroxide is used as an immune adjuvant in human vaccines for over 80 years. Being a Th2 stimulator, the classical gel‐like adjuvant, however, fails to generate CD8(+) T cell responses, which are important for cancer vaccines. Here, aluminum hydroxide is turn...
Autores principales: | Jiang, Hao, Wang, Qin, Li, Lin, Zeng, Qin, Li, Hanmei, Gong, Tao, Zhang, Zhirong, Sun, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770685/ https://www.ncbi.nlm.nih.gov/pubmed/29375970 http://dx.doi.org/10.1002/advs.201700426 |
Ejemplares similares
-
Vaccine Delivery: Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8(+) T Cell Responses (Adv. Sci. 1/2018)
por: Jiang, Hao, et al.
Publicado: (2018) -
Tumors and Their Microenvironment Dual‐Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer
por: Deng, Caifeng, et al.
Publicado: (2019) -
Enhanced Melanoma‐Targeted Therapy by “Fru‐Blocked” Phenyboronic Acid‐Modified Multiphase Antimetastatic Micellar Nanoparticles
por: Long, Yang, et al.
Publicado: (2018) -
Turn-by-Turn BPM Electronics Based on 500 MHz Log-Ratio Amplifier
por: Hu, K H, et al.
Publicado: (1999) -
Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy
por: Li, Hanmei, et al.
Publicado: (2017)